コンテンツへスキップ
Merck
  • Multilayer encapsulated mesoporous silica nanospheres as an oral sustained drug delivery system for the poorly water-soluble drug felodipine.

Multilayer encapsulated mesoporous silica nanospheres as an oral sustained drug delivery system for the poorly water-soluble drug felodipine.

Materials science & engineering. C, Materials for biological applications (2014-12-11)
Liang Hu, Hongrui Sun, Qinfu Zhao, Ning Han, Ling Bai, Ying Wang, Tongying Jiang, Siling Wang
要旨

We used a combination of mesoporous silica nanospheres (MSN) and layer-by-layer (LBL) self-assembly technology to establish a new oral sustained drug delivery system for the poorly water-soluble drug felodipine. Firstly, the model drug was loaded into MSN, and then the loaded MSN were repeatedly encapsulated by chitosan (CHI) and acacia (ACA) via LBL self-assembly method. The structural features of the samples were studied using scanning electron microscopy (SEM), transmission electron microscopy (TEM) and nitrogen adsorption. The encapsulating process was monitored by zeta-potential and surface tension measurements. The physical state of the drug in the samples was characterized by differential scanning calorimetry (DSC) and X-ray diffractometry (XRD). The influence of the multilayer with different number of layers on the drug release rate was studied using thermal gravimetric analysis (TGA) and surface tension measurement. The swelling effect and the structure changes of the multilayer were investigated to explore the relationship between the drug release behavior and the state of the multilayer under different pH conditions. The stability and mucosa adhesive ability of the prepared nanoparticles were also explored. After multilayer coating, the drug release rate was effectively controlled. The differences in drug release behavior under different pH conditions could be attributed to the different states of the multilayer. And the nanoparticles possessed good stability and strong mucosa adhesive ability. We believe that this combination offers a simple strategy for regulating the release rate of poorly water-soluble drugs and extends the pharmaceutical applications of inorganic materials and polymers.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
メタノール, suitable for HPLC, ≥99.9%
Sigma-Aldrich
エチルアルコール(純粋), 190 proof, for molecular biology
Sigma-Aldrich
メタノール, ACS reagent, ≥99.8%
Sigma-Aldrich
メタノール, suitable for HPLC, gradient grade, ≥99.9%
Sigma-Aldrich
ジエチルエーテル, anhydrous, ACS reagent, ≥99.0%, contains BHT as inhibitor
Sigma-Aldrich
メタノール, HPLC Plus, ≥99.9%
Sigma-Aldrich
スクロース, for molecular biology, ≥99.5% (GC)
Sigma-Aldrich
ジエチルエーテル, suitable for HPLC, ≥99.9%, inhibitor-free
Sigma-Aldrich
ジエチルエーテル, ACS reagent, anhydrous, ≥99.0%, contains BHT as inhibitor
Sigma-Aldrich
スクロース, ≥99.5% (GC)
Sigma-Aldrich
スクロース, ≥99.5% (GC), BioXtra
Sigma-Aldrich
メタノール, suitable for HPLC, gradient grade, suitable as ACS-grade LC reagent, ≥99.9%
Sigma-Aldrich
スクロース, BioUltra, for molecular biology, ≥99.5% (HPLC)
Sigma-Aldrich
メタノール, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., ≥99.8% (GC)
Sigma-Aldrich
メタノール, Laboratory Reagent, ≥99.6%
Sigma-Aldrich
エタノール, JIS special grade, ≥99.5%
USP
スクロース, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
ジエチルエーテル, contains BHT as inhibitor, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., ≥99.8% (GC)
Sigma-Aldrich
メタノール, ACS spectrophotometric grade, ≥99.9%
Sigma-Aldrich
スクロース, ≥99.5% (GC), BioReagent, suitable for cell culture, suitable for insect cell culture
Sigma-Aldrich
フルオロセインイソチオシアナート, アイソマー I, suitable for protein labeling, ≥90% (HPLC), powder
Sigma-Aldrich
フルオロセイン 5(6)-イソチオシアナート, BioReagent, suitable for fluorescence, mixture of 2 components, ≥90% (HPLC)
Sigma-Aldrich
メタノール, ACS reagent, ≥99.8%
Sigma-Aldrich
メタノール, BioReagent, ≥99.93%
Sigma-Aldrich
メタノール, Absolute - Acetone free
Sigma-Aldrich
メタノール, JIS special grade, ≥99.8%
Sigma-Aldrich
エタノール, SAJ first grade, ≥99.5%
USP
メチルアルコール, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
N,N′-ジスクシンイミジルカルボナート, ≥95%
Sigma-Aldrich
ジエチルエーテル, ACS reagent, ≥98.0%, contains ≤2% ethanol and ≤10ppm BHT as inhibitor